Hedge fund urges board shake-up at Novavax over struggling Covid vaccine
Published
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
Full ArticlePublished
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
Full Article